Pediatric oncology is the branch of medicine focused on diagnosing and treating cancer in children and adolescents. It covers the full arc of care, from the initial diagnosis through treatment, long-term monitoring, rehabilitation, and survivorship. Because childhood cancers behave differently from adult cancers at a biological level, pediatric oncology operates as its own distinct subspecialty with dedicated teams, treatment protocols, and research infrastructure.
How Childhood Cancer Differs From Adult Cancer
Cancer in adults typically develops from decades of accumulated DNA damage, driven by environmental exposures, lifestyle factors, and aging. Childhood cancers don’t follow that pattern. They arise from different biological mechanisms, often rooted in early development rather than long-term wear and tear. This distinction matters because it means the treatments that work well in adults frequently don’t translate directly to children.
At least 10% of children with cancer carry an inherited mutation in a cancer predisposition gene. Over 50 genetic syndromes are known to increase cancer risk in the first two decades of life, including Li-Fraumeni syndrome, neurofibromatosis type 1, and Beckwith-Wiedemann syndrome. But the majority of childhood cancers still arise without a clear hereditary cause.
Treatment decisions also carry different weight. In adults, doctors primarily weigh the benefits of therapy against short-term side effects. In children, the calculus shifts dramatically toward long-term consequences, since a five-year-old who survives cancer still has 70 or more years of life ahead. Every treatment choice has to account for how it will affect a developing body and brain decades later.
The Most Common Childhood Cancers
The cancers that affect children look nothing like the cancers most common in adults. Lung, breast, colon, and prostate cancers, which dominate adult oncology, are essentially absent in children. Instead, the most frequently diagnosed cancers in children and adolescents are leukemias (cancers of the blood and bone marrow), brain and central nervous system tumors, and lymphomas (cancers of the immune system). Soft tissue tumors, bone tumors, and germ cell tumors round out the list. Leukemia alone accounts for the largest share of childhood cancer diagnoses.
How Childhood Cancer Is Diagnosed
Diagnosing cancer in children involves a combination of blood work, imaging, and tissue sampling. One of the most common procedures is a bone marrow aspiration, where a small sample of marrow is drawn from the back of the hip bone using a needle. In children under 18 months, the shin bone is typically used instead. This test can reveal blood cancers, identify whether solid tumors have spread to the marrow, and monitor how well treatment is working.
For solid tumors, imaging plays a central role. MRI, CT scans, and ultrasound help locate tumors and determine their size and spread. Some children also need lumbar punctures to check whether cancer cells have reached the fluid surrounding the brain and spinal cord. Biopsies of tumor tissue, analyzed by specialized pathologists, confirm the specific type and subtype of cancer, which directly determines the treatment plan.
Treatment Approaches
The standard treatment for most childhood cancers combines chemotherapy and surgery, sometimes with radiation. These remain the backbone of pediatric cancer care, but the specifics vary enormously depending on the cancer type, its stage, and the child’s age.
Immunotherapy has become an increasingly important tool, particularly for cancers that don’t respond well to conventional treatment. One of the clearest success stories involves antibody therapy for neuroblastoma, a cancer of nerve tissue that primarily affects young children. With the addition of a targeted antibody treatment to standard care, 50 to 60% of children with high-risk neuroblastoma now survive long-term, a dramatic improvement for a disease that was once considered incurable. A newer approach called CAR-T therapy, which reprograms a patient’s own immune cells to attack cancer, has shown promise in certain blood cancers and is being refined for solid tumors. Other experimental strategies include cancer vaccines and treatments using natural killer cells from donors.
One notable feature of pediatric oncology is its deep connection to clinical research. About one in five children with cancer enrolls in a clinical trial, a rate far higher than in adult oncology. This culture of research participation is a major reason survival rates have improved so dramatically over the past several decades.
The Care Team
Pediatric oncology relies on large, specialized teams. According to guidelines from the American Academy of Pediatrics, a pediatric cancer center must include not just oncologists but also pathologists trained in handling specimens according to research protocols, nurses with specialized chemotherapy training, pharmacists with expertise in cancer drugs, anesthesiologists experienced with children, radiologists, respiratory therapists, and social workers with additional training in childhood cancer.
Beyond the medical staff, psychosocial professionals are considered integral team members, not optional additions. The field has formalized 15 standards for psychosocial care, covering everything from social interaction during treatment to school reentry support after therapy ends. A designated team member coordinates communication between the family, the hospital, and the child’s school to help minimize disruption to education and friendships. Child life specialists, psychologists, and social workers participate in patient care meetings alongside doctors and nurses.
What Long-Term Survivorship Looks Like
Surviving childhood cancer is not the same as being done with it. Treatment can leave lasting marks on a developing body, and many of these effects don’t appear until years or even decades later.
Heart disease is one of the most serious long-term risks. Childhood cancer survivors face a 30-year cumulative incidence of about 4.8% for significant cardiac problems, including heart failure and coronary artery disease. Certain chemotherapy drugs and radiation to the chest are the primary drivers, and the risk doesn’t level off over time. It continues to climb as survivors age.
Secondary cancers are another major concern. Survivors have a sixfold increased risk of developing a new, unrelated cancer compared to the general population, with a 30-year cumulative incidence of 20.5%. The most common secondary cancers include skin cancer, breast cancer, thyroid cancer, and brain tumors. Women who received chest radiation, for example, are recommended to begin annual mammograms and breast MRIs either eight years after radiation or at age 25, whichever comes later.
Cognitive effects are particularly common among survivors of brain tumors and acute lymphoblastic leukemia, the two diagnoses most likely to require treatments directed at the central nervous system. Deficits in processing speed, memory, and executive function (the ability to plan, organize, and manage tasks) can emerge during treatment and worsen over time. New memory problems have been documented appearing decades after therapy ended.
Because of these risks, childhood cancer survivors are recommended to follow a lifelong, risk-based monitoring plan tailored to their specific diagnosis and the treatments they received. This ongoing surveillance is a defining feature of pediatric oncology: the relationship between patient and care team doesn’t end when treatment does.
Supporting the Whole Family
Pediatric oncology treats a child, but the impact radiates through the entire family. Psychosocial care standards recognize this explicitly. Assessments of social and emotional needs happen at diagnosis, continue throughout treatment, and extend into survivorship. These evaluations include both the child and the parents, and they adapt based on the child’s developmental stage and preferences.
School reentry is a formal part of the care plan, not an afterthought. The oncology team provides information to school staff about the child’s diagnosis, what treatment involves, and what accommodations the child may need. For adolescents, maintaining peer relationships during treatment is a specific focus, with the care team actively creating opportunities for social interaction while accounting for infection risk and energy levels.